These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 1606170

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Composition of plasma ApoA-I-containing lipoprotein particles in children and adults.
    Bekaert ED, Alaupovic P, Knight-Gibson C, Blackett P, Ayrault-Jarrier M.
    Pediatr Res; 1991 Mar; 29(3):315-21. PubMed ID: 1903524
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J, Escolà-Gil JC, Rotllan N, Fiévet C, Vallez E, de la Torre C, Ribas V, Sloan JH, Blanco-Vaca F.
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [Abstract] [Full Text] [Related]

  • 7. Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery.
    Weidman SW, Ragland JB, Sabesin SM.
    J Lipid Res; 1982 May; 23(4):556-69. PubMed ID: 7097121
    [Abstract] [Full Text] [Related]

  • 8. Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia.
    Alaupovic P, Knight-Gibson C, Wang CS, Downs D, Koren E, Brewer HB, Gregg RE.
    J Lipid Res; 1991 Jan; 32(1):9-19. PubMed ID: 1901345
    [Abstract] [Full Text] [Related]

  • 9. Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).
    Alaupovic P, Hodis HN, Knight-Gibson C, Mack WJ, LaBree L, Cashin-Hemphill L, Corder CN, Kramsch DM, Blankenhorn DH.
    Arterioscler Thromb; 1994 Dec; 14(12):1906-13. PubMed ID: 7981178
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO, Samuelsson OG, Moberly J, Johansson AC, Ljungman S, Weiss LG, Knight-Gibson C, Alaupovic P.
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.
    Clay MA, Cehic DA, Pyle DH, Rye KA, Barter PJ.
    Biochem J; 1999 Feb 01; 337 ( Pt 3)(Pt 3):445-51. PubMed ID: 9895287
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of immunoaffinity chromatography for isolating human lipoproteins containing apolipoprotein B.
    McConathy WJ, Koren E, Wieland H, Campos EM, Lee DM, Kloer HU, Alaupovic P.
    J Chromatogr; 1985 Jul 12; 342(1):46-66. PubMed ID: 3930548
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
    Samuelsson O, Attman PO, Knight-Gibson C, Kron B, Larsson R, Mulec H, Weiss L, Alaupovic P.
    Nephron; 1997 Jul 12; 75(3):286-94. PubMed ID: 9069450
    [Abstract] [Full Text] [Related]

  • 17. Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease).
    Alaupovic P, Schaefer EJ, McConathy WJ, Fesmire JD, Brewer HB.
    Metabolism; 1981 Aug 12; 30(8):805-9. PubMed ID: 6790903
    [Abstract] [Full Text] [Related]

  • 18. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma.
    Cheung MC, Wolf AC, Illingworth DR.
    Biochim Biophys Acta; 1992 Oct 30; 1128(2-3):244-9. PubMed ID: 1420297
    [Abstract] [Full Text] [Related]

  • 19. Effect of thyroid hormone on plasma apolipoproteins and apoA- and apoB-containing lipoprotein particles.
    Liu XQ, Rahman A, Bagdade JD, Alaupovic P, Kannan CR.
    Eur J Clin Invest; 1998 Apr 30; 28(4):266-70. PubMed ID: 9615901
    [Abstract] [Full Text] [Related]

  • 20. The concept of apolipoprotein-defined lipoprotein families and its clinical significance.
    Alaupovic P.
    Curr Atheroscler Rep; 2003 Nov 30; 5(6):459-67. PubMed ID: 14525679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.